Oncology
1 drug is in development for Cervical Carcinoma.
- Companies
- 1
- Clinical trials
- 6
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Cervical Carcinoma pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
Drug Pipeline by Phase
Phase 1(1)
| Drug | Company |
|---|---|
| CTX131 | CRISPR Therapeutics AG (CRSP) |
About this indication
Cervical Carcinoma context
Oncology·MeSH: Uterine Cervical Neoplasms (D002583)
Narrower concept of MeSH descriptor Uterine Cervical Neoplasms
Prevalence
64.2 / 100K
Incidence
11.5 / 100K/yr
Frequently asked questions
How many drugs are in development for Cervical Carcinoma?
BioSniper tracks 1 drug in development for Cervical Carcinoma across 1 company.
How many clinical trials target Cervical Carcinoma?
There are 6 clinical trials targeting Cervical Carcinoma tracked by BioSniper.
What is the prevalence of Cervical Carcinoma?
The estimated prevalence of Cervical Carcinoma is approximately 64.2 per 100,000 population.